Cargando…

Learning About New Therapies: Phase 3 Clinical Studies—And Beyond

Detalles Bibliográficos
Autor principal: Riddle, Matthew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747890/
https://www.ncbi.nlm.nih.gov/pubmed/23970714
http://dx.doi.org/10.2337/dc13-1019
_version_ 1782280997356699648
author Riddle, Matthew C.
author_facet Riddle, Matthew C.
author_sort Riddle, Matthew C.
collection PubMed
description
format Online
Article
Text
id pubmed-3747890
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-37478902014-09-01 Learning About New Therapies: Phase 3 Clinical Studies—And Beyond Riddle, Matthew C. Diabetes Care Commentary American Diabetes Association 2013-09 2013-08-13 /pmc/articles/PMC3747890/ /pubmed/23970714 http://dx.doi.org/10.2337/dc13-1019 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Commentary
Riddle, Matthew C.
Learning About New Therapies: Phase 3 Clinical Studies—And Beyond
title Learning About New Therapies: Phase 3 Clinical Studies—And Beyond
title_full Learning About New Therapies: Phase 3 Clinical Studies—And Beyond
title_fullStr Learning About New Therapies: Phase 3 Clinical Studies—And Beyond
title_full_unstemmed Learning About New Therapies: Phase 3 Clinical Studies—And Beyond
title_short Learning About New Therapies: Phase 3 Clinical Studies—And Beyond
title_sort learning about new therapies: phase 3 clinical studies—and beyond
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747890/
https://www.ncbi.nlm.nih.gov/pubmed/23970714
http://dx.doi.org/10.2337/dc13-1019
work_keys_str_mv AT riddlematthewc learningaboutnewtherapiesphase3clinicalstudiesandbeyond